221 related articles for article (PubMed ID: 35998675)
1. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
[TBL] [Abstract][Full Text] [Related]
3. Laboratory testing for VITT antibodies.
Warkentin TE; Greinacher A
Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
5. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
[TBL] [Abstract][Full Text] [Related]
6. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
Warkentin TE; Greinacher A
Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
Atsushi Y
Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
[TBL] [Abstract][Full Text] [Related]
9. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
[TBL] [Abstract][Full Text] [Related]
10. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
11. [Novel disease entities due to antiplatelet factor 4 antibodies: HIT, aHIT, and VITT].
Yasumoto A
Rinsho Ketsueki; 2022; 63(5):454-462. PubMed ID: 35662171
[TBL] [Abstract][Full Text] [Related]
12. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia.
Favaloro EJ; Pasalic L; Henry B; Lippi G
Pathology; 2022 Apr; 54(3):254-261. PubMed ID: 35125202
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
Kondo M; Donikian D; Brighton TA
Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
16. Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.
Favaloro EJ; Pasalic L
Methods Mol Biol; 2023; 2663():405-415. PubMed ID: 37204726
[TBL] [Abstract][Full Text] [Related]
17. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.
Sachs UJ; Cooper N; Czwalinna A; Müller J; Pötzsch B; Tiede A; Althaus K
Thromb Haemost; 2021 Dec; 121(12):1622-1627. PubMed ID: 34169493
[TBL] [Abstract][Full Text] [Related]
18. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L; Esteban O; Wesche J; Dobosz P; Broto M; Puig SR; Fuhrmann J; Torres R; Serra J; Llevadot R; Palicio M; Wang JJ; Gordon TP; Lindhoff-Last E; Hoffmann T; Alberio L; Langer F; Boehme C; Biguzzi E; Grosse L; Endres M; Liman T; Thiele T; Warkentin TE; Greinacher A
Blood; 2023 Dec; 142(26):2305-2314. PubMed ID: 37883798
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]